Welcome to our dedicated page for Buda Juice news (Ticker: BUDA), a resource for investors and traders seeking the latest updates and insights on Buda Juice stock.
Buda Juice, Inc. develops and distributes Ultra Fresh™ cold-crafted juices, lemonades and wellness shots for grocery retailers through an end-to-end refrigerated supply chain. Its news centers on retail distribution, branded product availability, white-label platform growth, financial results and public-company capital actions following its NYSE American listing under BUDA.
Company updates describe the Fresh35°™ or continuous 35°F cold chain, fresh perimeter placement in supermarkets, expansion beyond Texas into additional grocery markets and the role of clean-label citrus-based beverages as an alternative to shelf-stable drinks and in-store juicing.
Buda Juice (NYSE American: BUDA) announced the underwriters fully exercised the 15% over-allotment in its initial public offering, adding 399,999 shares and bringing total shares sold to 3,066,666 at $7.50 per share for gross proceeds of approximately $23.0 million before fees. The offering has closed and BUDA began trading on January 8, 2026. The company said it is profitable and plans to use the capital to expand branded distribution, enter new markets and scale its white-label platform while marketing its UltraFresh™ cold-chain juice positioned in produce departments.
Buda Juice (NYSE American: BUDA) began regular-way trading on the NYSE American exchange on January 8, 2026 under the ticker BUDA. The company is described as a pioneer of the UltraFresh™ beverage category focused on cold-crafted citrus juices for supermarket fresh produce departments.
Buda Juice (NYSE:BUDA) priced an initial public offering of 2,666,667 shares at $7.50 per share, raising $20,000,000 of gross proceeds before underwriting discounts and offering expenses. The company granted the underwriter a 45-day option to purchase up to 400,000 additional shares (15%). Shares are expected to begin trading on NYSE American on January 8, 2026, and the offering is expected to close on January 9, 2026.
The company intends to use net proceeds to build production plants in South Carolina and Arizona/Nevada, expand Dallas capacity, support in-store marketing, and provide working capital. MDB Capital is the underwriter and the registration statement was declared effective on January 7, 2026.